Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
622.00    -12.00 (-1.89%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £502.84m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

25 May 2006 07:00

Bloomsbury Publishing PLC25 May 2006 25 May 2006 Bloomsbury Acquires Theatre List Bloomsbury Publishing Plc, ("Bloomsbury"), the children's, adult and referencebook publisher, announced today that its subsidiary A & C Black has acquiredMethuen Drama Ltd for a total cash consideration of £2.35m. Methuen Drama Ltd has over 700 titles in print and the list includes plays bytop contemporary authors such as Caryl Churchill, Michael Frayn and David Mametas well as established classics by Bertolt Brecht, Oscar Wilde and Dario Fo.The list also includes practical books for students that cover voice training,directing and stage management, a number of more general titles, theatrebiographies, diaries and letters. The acquisition is complementary to a number of A&C Black's publishingactivities including its established practical theatre list and the New Mermaidsseries of plays. A&C Black has also recently reached agreement with the ShawFoundation to publish a number of Bernard Shaw's most famous plays and thesewill be rolled in to the Methuen Drama list. The Company plans to develop theMethuen Drama list across all of the English speaking markets, exploiting itmore fully in the trade and educational spheres. Nigel Newton, Chairman of Bloomsbury Publishing Plc, said: "Methuen Drama is a highly prestigious name and has a list of well known authorsand playwrights. We have the sales and marketing expertise to exploit its listfully in the trade and educational markets and will be looking to add bothpractical theatre titles and new works which will become the classic plays ofthe future." The Methuen general list will stay with the current management and will be soldunder the name Methuen Publishing Ltd. Peter Tummons, Managing Director of Methuen said: 'I am delighted that the drama list and the Methuen Drama name will go to suchan old established house as A&C Black, backed by the entrepreneurial spirit ofBloomsbury. I'm sure the list will prosper in such good hands'. ENDS For further information, please contact: Tim Spratt/Charles PalmerFinancial Dynamics 020 7831 3113 Sandy Karon, PA to the Chief ExecutiveBloomsbury Publishing Plc 020 7494 6015 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
20th Mar 20257:00 amRNSTrading Update and Board Appointment
3rd Mar 20257:00 amRNSNotice of Trading Update
24th Feb 20254:27 pmRNSHolding(s) in Company
14th Feb 202510:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20257:00 amRNSBloomsbury reaches new agreement with Amazon
16th Dec 202410:05 amRNSHolding(s) in Company
16th Dec 20249:55 amRNSHolding(s) in Company - Replacement
11th Dec 202410:24 amRNSDirector/PDMR Shareholding
9th Dec 20249:18 amRNSDirector/PDMR Shareholding
26th Nov 202411:44 amRNSHolding(s) in Company
26th Nov 202410:35 amRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSUnaudited Interim Results
30th Sep 20247:00 amRNSNotice of Interim Results
2nd Sep 202411:31 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDirector/PDMR Shareholding
28th Aug 202410:57 amRNSDirector/PDMR Shareholding
16th Aug 20244:18 pmRNSAMENDMENT: BLOCK LISTING SIX MONTHLY RETURN
16th Aug 20249:42 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Aug 20245:36 pmRNSAwards under the 2023 Executive Share Plan
16th Jul 20243:41 pmRNSResults of the 2024 Annual General Meeting
16th Jul 20247:00 amRNSAGM Trading Update
14th Jun 20245:01 pmRNSAnnual Financial Report
14th Jun 20241:48 pmRNSBoard Appointment
29th May 20247:00 amRNSAcquisition
23rd May 20247:00 amRNSChairman Succession Announcement
23rd May 20247:00 amRNSAudited Preliminary Results
20th May 20247:00 amRNSInvestor Presentation
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.